Fecal Calprotectin Test Market revenue to hit USD 350 Million by 2035, says Research Nester
August 23, 2023 07:30 ET
|
Research Nester
New York, Aug. 23, 2023 (GLOBE NEWSWIRE) -- The global fecal calprotectin test market size is predicted to grow at a CAGR of over ~12% from 2023 to 2035. The market is projected to garner a revenue...
Fecal Calprotectin Test Market to Grow at 10.7% CAGR, Aiming for USD 355.8 Million by 2031 – TMR Report
May 24, 2023 06:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, May 24, 2023 (GLOBE NEWSWIRE) -- The global fecal calprotectin test market stood at US$ 126.9 million in 2022 and the global market is projected to reach US$...
Morphic Reports Positive Topline Results of the EMERALD-1 UC Main Cohort; Orally Administered MORF-057 Achieves Primary Endpoint and Demonstrates Clinically Meaningful Improvements Across Secondary and Exploratory Measures
April 25, 2023 07:00 ET
|
Morphic Therapeutic
-MORF-057 demonstrates statistically significant reduction of 6.4 points (p=0.002) from baseline at Week 12 in the Robarts Histopathology Index (RHI) Score- -MORF-057 achieves 25.7% clinical...
Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2023
April 25, 2023 06:59 ET
|
Morphic Therapeutic
-In EMERALD-1 Phase 2a trial in patients with ulcerative colitis, MORF-057 meets primary endpoint and demonstrates clinically meaningful improvements across secondary and exploratory measures with no...
Morphic Therapeutic to Host EMERALD-1 Topline Results Call on April 25, 2023
April 24, 2023 16:01 ET
|
Morphic Therapeutic
WALTHAM, Mass., April 24, 2023 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious...
Expanding Government Assistance is Controlling the Market, Microbiome Therapeutics Market to Grow By 32% CAGR through 2032, Says Fact.MR
December 08, 2022 09:00 ET
|
FACT.MR
Rockville, Dec. 08, 2022 (GLOBE NEWSWIRE) -- The microbiome therapeutics market size is estimated at US$ 112.20 Bn in 2022 and is anticipated to grow at a CAGR of 32% from 2022 to 2032. The...
Global Inflammatory Bowel Disease Treatment Market Research Report 2022 Featuring AbbVie, Biogen, Johnson & Johnson, Amgen, & UCB SA
November 08, 2022 06:13 ET
|
Research and Markets
Dublin, Nov. 08, 2022 (GLOBE NEWSWIRE) -- The "Inflammatory Bowel Disease Treatment Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global inflammatory...
First Wave BioPharma, Inc. Announces Pricing of $6.0 Million Public Offering
October 06, 2022 21:00 ET
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., Oct. 06, 2022 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the...
First Wave BioPharma’s CEO James Sapirstein to Present at Inaugural Roth Healthcare Opportunities Conference
September 28, 2022 07:00 ET
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., Sept. 28, 2022 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
U.S. Medical Foods Market to Surpass US$ 67,325.9 Million by 2030, Says Coherent Market Insights (CMI)
September 21, 2022 09:50 ET
|
CMI
Seattle, Sept. 21, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the U.S. Medical Foods market is estimated to be valued at US$ 19,067.9 million in 2022 and is expected to exhibit...